REFERENCES
- O'Rourke M. Mechanical principles in arterial disease. Hypertension. 1995; 26: 2–9
- Nitta K, Akiba T, Uchida K, et al. Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res. 2004; 27: 47–52
- Guerin AP, London GM, Marchais SJ, et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000; 15: 1014–1021
- London GM, Marchais SJ, Safar ME, et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int. 1990; 37: 137–142
- Halloc P. Arterial elasticity in man in relation to age as evaluated by the pulse wave velocity method. Arch Intern Med. 1934; 54: 770–798
- Kubo T, Miyata M, Minagoe S, et al. A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res. 2002; 25: 351–358
- Romero JC, Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999; 34(4)943–949
- Williams C, Kingwell BA, Burke K, et al. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am J Clin Nutr. 2005; 82(1)26–31
- Mahmud A, Feely J. Effect of angiotensin II receptor blockade on arterial stiffness: Beyond blood pressure reduction. Am J Hypertens. 2002; 15(12)1092–1095
- van Guldener C, Lambert J, ter Wee PM, et al. Carotid artery stiffness in patients with end-stage renal disease: No effect of long-term homocysteine-lowering therapy. Clin Nephrol. 2000; 53(1)33–41
- Dierkes J, Domrose U, Ambrosch A, et al. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease. Clin Nephrol. 1999; 51(2)108–115
- van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: A two-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol. 2001; 21(12)2072–2079
- Suzuki T, Yonemura K, Maruyama Y, et al. Impact of serum parathyroid hormone concentration and its regulatory factors on arterial stiffness in patients undergoing maintenance hemodialysis. Blood Purif. 2004; 22: 293–297
- Chuang SY, Chen CH, Cheng CM, et al. Combined use of brachial-ankle pulse wave velocity and ankle-brachial index for fast assessment of arteriosclerosis and atherosclerosis in a community. Int J Cardiol. 2005; 98: 99–105
- Nagano M, Nakamura M, Sato K, et al. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis. 2005; 180: 189–195
- Shinohara K, Shoji T, Tsujimoto Y, et al. Arterial stiffness in predialysis patients with uremia. Kidney Int. 2004; 65: 936–943
- Ichihara A, Hayashi M, Kaneshiro Y, et al. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis. 2005; 45(5)866–874
- Agata J, Nagahara D, Kinoshita S, et al. Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J. 2004; 68(12)1194–1198
- Schiffrin EL, Park JB, Pu Q. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens. 2002; 20(1)71–78
- Bostom AG, Shemin D, Verhoef P, et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol. 1997; 17(11)2554–2558
- Janssen MJ, van Guldener C, de Jong GM, et al. Folic acid treatment of hyperhomocysteinemia in dialysis patients. Miner Electrolyte Metab. 1996; 22(1–3)110–114
- Bircher G. Nutrition in chronic renal failure. Comprehensive Clinical Nephrology, RJ Johnson, J Fehally. Mosby, LondonUK 2003; 940
- Gokal R, Harty J. Nutrition and peritoneal dialysis. Handbook of Nutrition and the Kidney, WE Mitch, S Klahr. Lippincott-Raven, Washington, DC 1998; 284
- Woodside JV, McMahon R, Gallagher AM, et al. Total homocysteine is not a determinant of arterial pulse wave velocity in young healthy adults. Atherosclerosis. 2004; 177(2)337–344
- van Dijk RA, Rauwerda JA, Steyn M, et al. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: A two-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol. 2001; 21(12)2072–2079
- Blacher J, Demuth K, Guerin AP, et al. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol. 1998; 18: 535–541
- Wilkinson IB, Prasad K, Hall IR, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002; 39(6)1005–1011
- Dart AM, Lacombe F, Yeoh JK, et al. Aortic distensibility in patients with isolated hypercholesterolemia, coronary artery disease, or cardiac transplant. Lancet. 1991; 338(8762)270–273